titrationd Other Overall risk category Admissions/pt/year in control High Risk - Short interventions 46% All NS None ADHF 1.0 All None 45% Most New 1.0 High Risk - Mid-length interventions PREFER trial Brannstrom 2014 50 None NS All None suitable for palliative care Severe 2.9 (high) None None 20% All from clinic for "complex HF" Titration 0.5 (low) NS 90% mean NYHA patients ADHF 2.4 (high) 40% All NS 60% from geriatric ward (ave J-HOMECARE trial Tsuchihashi-makaya 2013341 NS All 5% 50% ADHF NS High Risk - Long interventions Auckland-HF Doughty 2002103 NS All All 10% ADHF 1.6 NS All All 25% ADHF NS NS All 35% None ADHF 0.6 COACH trial Jaarsma 2008157 - basic NS All 50% 35% ADHF 0.7 Referral and approach to care Chronic Heart Failure NICE 2018. All rights reserved. Subject to Notice of rights. ISBN: Risk strata (proportions are estimates) COACH Jaarsma 2008157 - enhanced NS All 50% 35% ADHF 0.7 DEAL-HF trial De la Porte 2007 87 NS 30% All 30% Severe NS Del sindaco 200791 NS All 60% 50% Older patients ADHF NS OPTIMAL trial Mejhert 2004 220 PRICE trial Atienza 200422 NS All 90% NS ADHF 0.5 (low) Low Risk (stable HF) - Long interventions NS NS 35% 25% Nil low risk 0.6 HICMan trial Peters-klimm 2010 257 None 25% 30% 25% Nil low risk 0.4 (low) None NS 50% 40% Nil low risk NS Northstar trial Schou 2013 300 None None 11% None Nil low risk 0.8 NS 25% mean NYHA NS Older patients Nil low risk 0.7 (a) New dx = identified as new diagnosis of heart failure at recruitment. 